Form 4 for REGN Regeneron Pharmaceuticals
Accepted 2021-08-27 00:00:00 ET · period of report 2021-08-25 · accession 0001708138-21-000066 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-08-27 | 2021-08-25 | REGN | VAGELOS P ROY | Dir | M - OptEx | $179.13 | +75.0K | 366.1K | +26% | +$13.43M |
| D | 2021-08-27 | 2021-08-25 | REGN | VAGELOS P ROY | Dir | F - Tax | $667.39 | -49.3K | 316.8K | -13% | -$32.89M |
| D | 2021-08-27 | 2021-08-25 | REGN | VAGELOS P ROY | Dir | M - OptEx | $0.00 | -75.0K | 75.0K | -50% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-08-25 | M | A | 75,000 | $179.13 | 366,090 | D | — | — | |
| 2 | Common | Common Stock | 2021-08-25 | F | D | 49,282 | $667.39 | 316,808 | D | — | — | |
| 3 | Derivative | Non-Qualified Stock Option (right to buy) | 2021-08-25 | M | D | 75,000 | $0.00 | 75,000 | D | $179.13 · — to 2022-12-14 | 75,000 Common Stock | (F2) The stock option award vests in four equal annual installments, commencing one year after the date of grant. |